Not applicableUnknownNCT01854112What this trial is testingHelical Irradiation of Total Skin (HITS) for T Cell LymphomaWho this might be right forT-cell Lymphoma Far Eastern Memorial Hospital 1
Testing effectiveness (Phase 2)Study completedNCT01466881What this trial is testingAlisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+4 more National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT06784167What this trial is testingVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentWho this might be right forChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more OHSU Knight Cancer Institute 45
Early research (Phase 1)Ended earlyNCT00649584What this trial is testingA Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive MalignanciesWho this might be right forDisease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin Seagen Inc. 44
Early research (Phase 1)Study completedNCT00641381What this trial is testingCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaWho this might be right forLymphoma City of Hope Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT03497533What this trial is testingTreatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19Who this might be right forNon-hodgkin Lymphoma,B Cell Timmune Biotech Inc. 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT06548347What this trial is testingA Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell LymphomaWho this might be right forPeripheral T Cell Lymphoma Shanghai YingLi Pharmaceutical Co. Ltd. 606
Testing effectiveness (Phase 2)Active Not RecruitingNCT06093841What this trial is testingRelmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHLWho this might be right forLymphoma, Large B-Cell, DiffuseFollicular Lymphoma Grade 3BHigh-grade B-cell Lymphoma+1 more Shanghai Ming Ju Biotechnology Co., Ltd. 46
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT00958854What this trial is testingFludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell LymphomaWho this might be right forLymphoma Cancer Research UK 37
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Testing effectiveness (Phase 2)Study completedNCT03493451What this trial is testingStudy of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell NeoplasmsWho this might be right forPeripheral T Cell LymphomaPTCLExtranodal NK/T-cell Lymphoma+16 more BeiGene 77
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Active Not RecruitingNCT03952078What this trial is testingA Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell LymphomaWho this might be right forT-cell Lymphoma Corvus Pharmaceuticals, Inc. 151
Early research (Phase 1)Study completedNCT01804335What this trial is testingCD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)Who this might be right forLymphoma M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07168317What this trial is testingTislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITLWho this might be right forNew Diagnosed Angioimmunoblastic T-Cell Lymphoma The Affiliated Hospital of Xuzhou Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT04509466What this trial is testingClinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLWho this might be right forExtranodal NK/T-cell Lymphoma, Nasal Type CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 41
Large-scale testing (Phase 3)Looking for participantsNCT06724237What this trial is testingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more Eastern Cooperative Oncology Group
Early research (Phase 1)UnknownNCT05349266What this trial is testingAssessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyWho this might be right forNon-Hodgkin's Lymphoma Zhejiang University 16
Early research (Phase 1)WithdrawnNCT02487459What this trial is testingSafety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic MalignanciesWho this might be right forHematologic Malignancies Bellicum Pharmaceuticals